Multivariate Analysis of Serum High Sensitivity C-Reactive Protein in Patients With Acute Phase Stroke
- Conditions
- National Institutes of Health Stroke ScaleSerum High Sensitivity C-Reactive ProteinStroke
- Registration Number
- NCT02171858
- Lead Sponsor
- Hospital Central Sur de Alta Especialidad
- Brief Summary
Stroke is one of main causes of death and impairment worldwide. Objective of this study is to analyze serum High Sensitivity C-Reactive Protein in acute phase stroke in patients attended at Petróleos Mexicanos Hospital Central Sur de Alta Especialidad and to correlate with stroke extension and clinical features.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 28
- Patients suspected of acute phase stroke who arrive to emergency room at our hospital
- Patients affiliated to Petróleos Mexicanos medical system
- Patients of any gender
- Patients between 18 and 80 years old
- Stroke provoked by angiographic procedure
- Pregnancy
- Patient under chemotherapy or radiotherapy
- Recently surgery or trauma among last 30 days
- Heparin usage
- Stroke and/ or thrombolysis history
- Active infection
- Liver disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measure of serum High sensitivity C-Reactive Protein level within the first 8 hours since admission to hospital Serum levels of serum High sensitivity C-Reactive Protein will be measured in patients with suspicion of stroke at the emergency room within the first 8 hours of arrival at our hospital
- Secondary Outcome Measures
Name Time Method National Institutes of Health Stroke Scale within the first 4 hours since admission to emergency room clinical impact of stroke will be determined by neurology and neurosurgery department at admission to emergency room of our hospital
Trial Locations
- Locations (1)
Hospital Central Sur Alta Especialidad
🇲🇽Mexico city, Tlalpan, Mexico